+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Identification of long non-coding RNAs as novel biomarker and potential therapeutic target for atrial fibrillation in old adults

Identification of long non-coding RNAs as novel biomarker and potential therapeutic target for atrial fibrillation in old adults

Oncotarget 7(10): 10803-10811

Atrial fibrillation (AF) is a highly prevalent cardiac arrhythmia disease, which widely leads to exacerbate heart failure and ischemic stroke in elder world. Recently, long non-coding RNAs (lncRNAs), a subclass of noncoding RNAs, have been reported to play critical roles in pathophysiology of cardiac heart. However, little is known of their role in cardiac arrhythmia. In the present study, we investigated the expression levels of lncRNAs of AF patients and healthy people with Agilent Human lncRNA array for the first time. 177 lncRNAs of 78243 and 153 mRNAs of 30215 tested were identified to be differentially expressed (≥ 2-fold change), indicating that the expression of many lncRNAs are upregulated or downregulated in AF. Among these, NONHSAT040387 and NONHSAT098586 were the most upregulated and downregulated lncRNAs. Real time quantitative PCR were employed to validate the microarray analysis findings, and the results confirmed the consistence. GO and KEGG pathway analysis were applied to explore the potential lncRNAs functions, some pathways including oxygen transporter activity and protein heterodimerization activity were speculated to be involved in AF pathogenesis. These results shed some light on lncRNAs' physiologic functions and provide useful information for exploring potential therapeutic treatments for heart rhythm disease.

(PDF emailed within 1 workday: $29.90)

Accession: 058039825

Download citation: RISBibTeXText

PMID: 26908457

Related references

Identification of a long non-coding RNA as a novel biomarker and potential therapeutic target for metastatic prostate cancer. Oncotarget 5(3): 764-774, 2015

Identification of Potential Key Long Non-Coding RNAs and Target Genes Associated with Pneumonia Using Long Non-Coding RNA Sequencing (lncRNA-Seq): A Preliminary Study. Medical Science Monitor 22: 3394-3408, 2016

Long Non-coding RNA and microRNAs as Novel Potential Biomarker and Therapeutic Target in the Treatment of Gastrointestinal Cancers. Current Pharmaceutical Design 24(39): 4599-4600, 2019

Non-coding RNA: a potential biomarker and therapeutic target for sepsis. Oncotarget 8(53): 91765-91778, 2017

Long non-coding RNAs expression profile in HepG2 cells reveals the potential role of long non-coding RNAs in the cholesterol metabolism. Chinese Medical Journal 128(1): 91-97, 2015

Receptor for advanced glycation end products (RAGE): novel biomarker and therapeutic target for atrial fibrillation. International Journal of Cardiology 168(5): 4802-4804, 2014

Transcriptome analysis of canine cardiac fat pads: involvement of two novel long non-coding RNAs in atrial fibrillation neural remodeling. Journal of Cellular Biochemistry 116(5): 809-821, 2015

Mechanisms with clinical implications for atrial fibrillation-associated remodeling: cathepsin K expression, regulation, and therapeutic target and biomarker. Journal of the American Heart Association 2(6): E000503, 2014

Long non-coding RNAs in ocular diseases: new and potential therapeutic targets. Febs Journal 2019, 2019

Long non-coding RNAs as potential biomarkers and therapeutic targets for gliomas. Medical Hypotheses 81(2): 319-321, 2014

The Function and Therapeutic Potential of Long Non-coding RNAs in Cardiovascular Development and Disease. Molecular Therapy. Nucleic Acids 8: 494-507, 2017

Potential of long non-coding RNAs in cancer patients: From biomarkers to therapeutic targets. International Journal of Cancer 140(9): 1955-1967, 2016

'Lnc'-ing Wnt in female reproductive cancers: therapeutic potential of long non-coding RNAs in Wnt signalling. British Journal of Pharmacology 174(24): 4684-4700, 2017

Potential long non-coding RNAs to be considered as biomarkers or therapeutic targets in gastric cancer. Frontiers in Genetics 4: 210, 2013

Exosomal long non-coding RNAs: biological properties and therapeutic potential in cancer treatment. Journal of Zhejiang University. Science. B 20(6): 488-495, 2019